Novo Nordisk cuts forecasts again amid drug competition
Danish pharmaceutical giant Novo Nordisk cuts sales and profit forecasts for second time amid intensifying competition in weight-loss drug market.
Category : Search result: pharmaceutical sales
Wisconsin Badgers to Sell Alcohol at Football Games
The University of Wisconsin-Madison joins the Big Ten alcohol revolution, bringing beer and wine sales to Camp Randall Stadium for the 2024 season in a major policy shift.
Unbeatable TV Deals 2024: Smart Savings Guide
Discover the year's best television bargains with our expert guide to cutting-edge 4K, QLED, and OLED screens from Samsung, LG, Sony and more. Save big without compromising on quality!
Big Pharma's Tax Breaks: Calls for Transparency Grow
Pharmaceutical giants face mounting pressure to justify massive tax incentives amid concerns over NHS funding and pandemic-era profit surges. Westminster demands clarity on whether public investment delivers fair returns.
UK patients face treatment delays in pharma pricing crisis
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
October 2025 Sales: Your Ultimate UK Deal Guide
Discover the biggest October sales events across retail, tech, fashion and homeware. Our expert guide reveals when and where to find the best discounts this autumn.
UK productivity downgrade sparks tax rise fears
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Major Statin Recall: 140,000 Bottles Withdrawn
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
New Alzheimer's Drug Slows Brain Decline in Trial
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
Gold Purchases Drive UK Retail Sales to Highest Since 2022
Britain's retail sector shows surprising resilience with September sales reaching their highest point in over two years, driven by strong jewellery and watch purchases ahead of anticipated Budget measures.
NHS patients denied vital medications in supply crisis
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
UK beer sales plummet amid cost of living crisis
New industry data reveals British drinkers are cutting back on beer purchases amid rising prices, with supermarkets and pubs experiencing significant sales declines.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
US Bible sales surge amid political tensions
American conservative commentator Charlie Kirk's viral claim about rising Bible purchases ignites conversation about religion's role in modern politics and cultural shifts
Trump's Ozempic Remark Hits Pharma Stocks
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Trump's Ozempic Price Pledge Shakes Pharma Markets
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
California declares emergency over insulin prices
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
Trump's FDA Win: IVF Drug Approved Despite Opposition
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
New weight loss jab shows unprecedented 24% reduction
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
J&J Pays $700M in Talc Cancer Scandal Settlement
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Johnson & Johnson Faces UK Lawsuit Over Talc Cancer Claims
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Johnson & Johnson £50B talc cancer settlement
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
WHO Alert: Contaminated Cough Syrups Linked to Child Deaths
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
Opium painkiller returns to England and Wales after 50 years
In a landmark pharmaceutical reversal, the opium-based pain medication Opium is set to be reintroduced in England and Wales after being withdrawn from the market nearly five decades ago, offering new hope for chronic pain sufferers.
Native Americans denied diabetes drugs amid weight loss craze
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.
AstraZeneca cuts drug prices for NHS in Trump-backed deal
Pharmaceutical giant AstraZeneca agrees to major price reductions on life-saving medications for NHS patients in unprecedented deal supported by former President Trump, promising significant savings for Britain's healthcare system.
Trump pressured AstraZeneca on US drug prices
Exclusive investigation reveals how Donald Trump pressured AstraZeneca to slash US drug prices while keeping UK costs high, exposing stark transatlantic healthcare divide.
AstraZeneca to Provide Cancer Drugs to Medicaid Patients
In a groundbreaking healthcare development, AstraZeneca announces it will provide expensive cancer medications to low-income Americans through Medicaid, challenging pharmaceutical industry norms.
Page 1 of 4